It's All About/Juvenile Diabetes Research Foundation/Winston-Salem/Type None Diabetes
Since its founding more than 40 years ago by parents of children affected by type 1 diabetes, the Juvenile Diabetes Research Foundation (JDRF) has been committed to finding a cure for all those individuals living with the disease. Today, JDRF acknowledges that this commitment will not likely be fulfilled in the near term. Although our ultimate goal—curing type 1 diabetes—remains unchanged, we are equally committed to better treating and preventing the disease. These goals aim to ensure that both children and adults living with type 1 diabetes remain healthy so that they can fully benefit from a cure when it becomes available. JDRF focuses on supporting the development and delivery of new therapies and devices that will ease the daily burden and challenges of managing type 1 diabetes and on the prevention of diabetes complications. Additionally, to protect future generations from developing type 1 diabetes, JDRF is supporting approaches to prevent the disease. Winston-Salem has grown to be an area known for its diversity of business and community. With a strong and unwavering commitment to the arts, excellence in healthcare research and technology, and opportunities for specialized and advanced education. Winston-Salem truly is the City of Arts and Innovation.
Twentieth century businesses, such as R. J. Reynolds Tobacco and the Hanes companies, also shaped Winston-Salem by bringing remarkable wealth to the city and endowing it with an impressive list of institutions and foundations. Their rise to prominence only furthered the spirit of entrepreneurship that has characterized the city since its earliest days, and which remains in evidence today as the city’s economy shifts from manufacturing to finance, medicine and technology. Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. In type 1 diabetes, the body does not produce insulin. The body breaks down the sugars and starches you eat into a simple sugar called glucose, which it uses for energy. Insulin is a hormone that the body needs to get glucose from the bloodstream into the cells of the body. With the help of insulin therapy and other treatments, even young children can learn to manage their condition and live long, healthy lives.
Type 1 diabetes signs and symptoms can come on quickly and may include:
Bed wetting in children who previously didn’t wet the bed during the night;
Extreme hunger;Unintended weight loss;
Irritability and other mood changes;
Fatigue and weakness;
In females, a vaginal yeast infection. List of Video Credits can be found here http://broadcaster.beazil.net/public/credits/youtube/videos/42246 JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To conclude, the main issues should be pointed out –
Insulin Pump Therapy,precise,make a tax-deductive donation,certified diabetes educator,preventive therapies,Political advocacy,Recognized Diabetes Education Programs,DPP-4 inhibitors,The Land of the Sky,impaired glucose tolerance,Treatment research,NPH insulin,Pathaway to Prevention,blood glucose meter,Diabetes Research,gestational diabetes mellitus,HAPO Study,charity,NPH Humulin N,very-long-acting insulin,Kidney Disease,2-h plasma glucose value,70/30 insulin,Aaron Kowalski,symptoms of T1D,insulin-dependent diabetes mellitus,IFG,Continuous glucose monitoring,help,SGLT2 inhibitors,secondary diabetes,sugar diabetes,negative diabetes associated autoantibodies,get involved,Medical Device,support,The Walk to Cure Diabetes,join our community,engage,NRTIs,blood glucose level,hyperosmolar hyperglycemic nonketotic syndrome,patient self-monitoring of blood glucose,ketone,Grant Management.